Usona Institute is a medical research organization dedicated to the exploration and development of consciousness-expanding medicines. They aim to discover new treatments for challenging mental health conditions, contributing to new pathways of healing and connection for those in need. To achieve this, Usona collaborates with scientists, clinicians, and leaders worldwide, expediting the knowledge and work in the field of psychedelic science. They have developed several programs that support clinical research, including Medicinal Chemistry, Investigational Drug Supply, and Training/Education. The Usona team consists of experienced and published professionals, ranging from scientists and clinicians to researchers and clinical administrators. With advanced skills in psychiatry, integrative medicine, medicinal chemistry, pharmaceutical manufacturing, quality assurance, and regulatory affairs, they bring a wealth of expertise to their research initiatives. Their collective experience spans multiple countries, ensuring a global perspective on their work. Usona is currently conducting clinical trials to evaluate the safety and efficacy of psilocybin and 5-MeO-DMT, following the strict guidelines of the US Food and Drug Administration and other regulatory bodies. Through their research, training, and Investigational Drug and Materials Supply Program, they collaborate with a global network of scientists advancing the field of psychedelic science. Usona Institute operates from a unique campus, the first of its kind designed specifically for novel therapeutic practices. The facility emphasizes set and setting, with the physical environment optimized for sound, light, and all senses. Centered around therapy, Usona bridges medical research with integrative healing practices. The campus serves as a global hub for scientific education, research, and the establishment of best practices in psychedelic sciences.